Dr. Povas - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-01-01
To: 2025-12-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | 13,223 | 29,256 | 21,155 | 15,793 | 11,216 | 13,377 | 9,197 | 14,459 |
| Profit before tax | -1,403 | 9,218 | 7,319 | 7,356 | 0 | 4,465 | -3,094 | -84 |
| Net profit | -1,403 | 8,757 | 6,920 | 6,967 | -22 | 4,229 | -2,965 | -95 |
| Equity | -1,359 | 7,398 | 14,318 | 21,285 | 16,931 | 21,160 | 38,195 | 38,100 |
| Liabilities | - | - | - | 1,157 | 149 | 236 | 0 | 271 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 1,489 | 993 |
| Current assets | 11,567 | 9,935 | 14,801 | 22,442 | 17,080 | 21,396 | 36,706 | 37,378 |
| Total assets | 11,567 | 9,935 | 14,801 | 22,442 | 17,080 | 21,396 | 38,195 | 38,371 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 12 | 238 | - |
|
Financial indicators
|
||||||||
| Revenue change y/y | -42.9% | +121.3% | -27.7% | -25.3% | -29.0% | +19.3% | -31.2% | +57.2% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | -12.1% | 88.1% | 46.8% | 31.0% | -0.1% | 19.8% | -7.8% | -0.2% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | 118.4% | 48.3% | 32.7% | -0.1% | 20.0% | -7.8% | -0.2% |
| Profit margin Net profit margin. Shows the overall profitability of the company. | -10.6% | 29.9% | 32.7% | 44.1% | -0.2% | 31.6% | -32.2% | -0.7% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | -10.6% | 31.5% | 34.6% | 46.6% | 0.0% | 33.4% | -33.6% | -0.6% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 0.1 | 0.0 | 0.0 | - | 0.0 |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | - | - | - | - | - | - | - |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Dr. Povas - Social security debts
The company had no debts to Sodra
Dr. Povas - VMI tax arrears
The company had no tax arrears (debts) to the State Tax Inspectorate
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Dr. Povas, MB (code 304408714) is a Small partnership engaged in the retail sale of bread, cake and confectionery. In the latest financial year, 2025, the company generated revenue of €14.5K, up 57.2% year on year and 8.1% over two years. Net profit was slightly negative at €95, after a loss of €3.0K in 2024 and a profit of €4.2K in 2023. This shows a recovery in sales in 2025, while profitability remained under pressure. The 2025 profit margin was -0.7%. At year-end, total assets stood at €38.4K, equity at €38.1K and liabilities at €271, indicating a very strong balance sheet position. The equity ratio was 99.3% and debt-to-equity was 0.01. Asset turnover was 0.38x, reflecting modest revenue generation relative to the asset base. ROE and ROA were both -0.2% in 2025.